This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Pacific Northwest Udall Center (PANUC) Clinical Core (PANUC)

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by Cyrus Zabetian, University of Washington
Sponsor:
Information provided by (Responsible Party):
Cyrus Zabetian, University of Washington
ClinicalTrials.gov Identifier:
NCT01720810
First received: October 31, 2012
Last updated: May 28, 2017
Last verified: May 2017
  Purpose
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.

Condition
Parkinson Disease Cognitive Impairment

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pacific Northwest Udall Center (PANUC) Clinical Core

Resource links provided by NLM:


Further study details as provided by Cyrus Zabetian, University of Washington:

Estimated Enrollment: 2000
Study Start Date: March 2010
Estimated Study Completion Date: June 2020
Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All subjects undergo the following procedures:

  • Interview to collect data on medical history and demographics
  • Neurological examination
  • Questionnaires about mood, activities of daily living, and environmental exposures.
  • Psychometric tests

Study companions might also be asked to complete questionnaires about the participant's thinking and memory, activities of daily living, sleep, and neuropsychiatric symptoms.

Criteria

Inclusion Criteria:

  • Diagnosis of Parkinson disease
  • Over 18 years of age

Exclusion Criteria:

- Under 18 years of age

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01720810

Contacts
Contact: Louren Reed (206) 277-5516 louren@uw.edu

Locations
United States, Washington
VA Puget Sound Health Care System Recruiting
Seattle, Washington, United States, 98108
Contact: Louren Reed    206-277-5516    louren@uw.edu   
Principal Investigator: Cyrus P Zabetian, MD, MS         
Sponsors and Collaborators
University of Washington
  More Information

Responsible Party: Cyrus Zabetian, Associate Professor, Neurology, University of Washington
ClinicalTrials.gov Identifier: NCT01720810     History of Changes
Other Study ID Numbers: 37855
Study First Received: October 31, 2012
Last Updated: May 28, 2017

Additional relevant MeSH terms:
Parkinson Disease
Cognition Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 22, 2017